Tarbox Family Office’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Tarbox Family Office’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$1K	–	1425
2019 Q4	$1K	Hold	1,000	–	–	﹤0.01%	1111
2019 Q3	$1K	Hold	1,000	–	–	﹤0.01%	1085
2019 Q2	$1K	Hold	1,000	–	–	﹤0.01%	1091
2019 Q1	$0	Hold	1,000	–	–	﹤0.01%	646
2018 Q4	$0	Hold	1,000	–	–	﹤0.01%	666
2018 Q3	$1K	Hold	1,000	–	–	﹤0.01%	613
2018 Q2	$0	Hold	1,000	–	–	﹤0.01%	655
2018 Q1	$0	Buy	+1,000	New	+$402	﹤0.01%	669

Tarbox Family Office's GCVRZ Position: Q1 2020 in Review

Tarbox Family Office sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 1,000 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in GCVRZ in Q1 2018 and held it in 8 quarters. The position peaked at $1K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Tarbox Family Office reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Tarbox Family Office sold 1,000 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1K.
Tarbox Family Office first reported a position in Sanofi Contingent Value Rights in Q1 2018 and held it in 8 quarters.
Tarbox Family Office's Sanofi Contingent Value Rights position peaked at $1K in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Tarbox Family Office's 13F filing for Q1 2020, filed 30 Apr 2020.